The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
Open accessAbstract
The physiological regulation of the immune system encompasses comprehensive anti‐inflammatory mechanisms that can be harnessed for the treatment of infectious and inflammatory disorders. Recent studies indicate that the vagal nerve, involved in control of heart rate, hormone secretion and gastrointestinal motility, is also an immunomodulator. In experimental models of inflammatory diseases, vagal nerve stimulation attenuates the production of proinflammatory cytokines and inhibits the inflammatory process. Acetylcholine, the principal neurotransmitter of the vagal nerve, controls immune cell functions via the alpha7 nicotinic acetylcholine receptor (alpha7nAChR). From a pharmacological perspective, nicotinic agonists are more efficient than acetylcholine at inhibiting the inflammatory signaling and the production of proinflammatory cytokines. This ‘nicotinic anti‐inflammatory pathway’ may have clinical implications as treatment with nicotinic agonists can modulate the production of proinflammatory cytokines from immune cells. Nicotine has been tested in clinical trials as a treatment for inflammatory diseases such as ulcerative colitis, but the therapeutic potential of this mechanism is limited by the collateral toxicity of nicotine. Here, we review the recent advances that support the design of more specific receptor‐selective nicotinic agonists that have anti‐inflammatory effects while eluding its collateral toxicity. British Journal of Pharmacology(2007)151, 915–929; doi:10.1038/sj.bjp.0707264
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841 · cited 1×
“One of the most dramatic examples of this process is ‘severe sepsis’, the leading cause of death in intensive care units and one of the principal causes of death in developed societies (Martin et al., 2003).”
BackgroundHost-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 2×
“system must display a regulated response to either beneficial or pathogenic microbes (Backhed et al., 2005).”
BackgroundVagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000) · Nature · doi:10.1038/35013070 · Cited by 4,211
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
Tracey, K. J. (2002) · Nature · doi:10.1038/nature01321 · Cited by 3,728
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S., Li, J. H., Wang, H., Yang, H., Ulloa, L., et al. (2003) · Nature · doi:10.1038/nature01339 · Cited by 3,228
Self-citationStroke-Associated Pneumonia: Major Advances and Obstacles
Hannawi, Y., Hannawi, B., Rao, C. P. V., Suarez, J. I., & Bershad, E. M. (2013) · Cerebrovascular Diseases · doi:10.1159/000350199 · Cited by 1,656
Structure and gating mechanism of the acetylcholine receptor pore
Miyazawa, A., Fujiyoshi, Y., & Unwin, N. (2003) · Nature · doi:10.1038/nature01748 · Cited by 1,270
Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220
Effects of cigarette smoke on the immune system
Sopori, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri803 · Cited by 1,217
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
Wang, H., Liao, H., Ochani, M., Justiniani, M., Lin, X., Yang, L., Al-Abed, Y., Wang, H., Metz, C., Miller, E. J., et al. (2004) · Nature Medicine · doi:10.1038/nm1124 · Cited by 1,170
Self-citationde Jonge, W. J., van der Zanden, E. P., The, F. O., Bijlsma, M. F., van Westerloo, D. J., Bennink, R. J., Berthoud, H.-R., Uematsu, S., Akira, S., van den Wijngaard, R. M., et al. (2005) · Nature Immunology · doi:10.1038/ni1229 · Cited by 1,074
Microglia as neuroprotective, immunocompetent cells of the CNS
Streit, W. J. (2002) · Glia · doi:10.1002/glia.10154 · Cited by 919
β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity
Wang, H.-Y., Lee, D. H. S., D'Andrea, M. R., Peterson, P. A., Shank, R. P., & Reitz, A. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5626 · Cited by 822
Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway
Ulloa, L., Doody, J., & Massagué, J. (1999) · Nature · doi:10.1038/17826 · Cited by 812
Self-citationLevy, D. E., & Lee, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15650 · Cited by 810
Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis
Heeschen, C., Jang, J. J., Weis, M., Pathak, A., Kaji, S., Hu, R. S., Tsao, P. S., Johnson, F. L., & Cooke, J. P. (2001) · Nature Medicine · doi:10.1038/89961 · Cited by 800
Cigarette Smoking and Invasive Pneumococcal Disease
Nuorti, J. P., Butler, J. C., Farley, M. M., Harrison, L. H., McGeer, A., Kolczak, M. S., & Breiman, R. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421002 · Cited by 798
Levy, D. E., & Lee, C.-K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215650 · Cited by 734
Interleukin (IL)-10 Inhibits Nuclear Factor кB (NFкB) Activation in Human Monocytes
Wang, P., Wu, P., Siegel, M. I., Egan, R. W., & Billah, M. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9558 · Cited by 711
Huston, J. M., Ochani, M., Rosas-Ballina, M., Liao, H., Ochani, K., Pavlov, V. A., Gallowitsch-Puerta, M., Ashok, M., Czura, C. J., Foxwell, B., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052362 · Cited by 683 · cited 4×
“According to the recent implication of the spleen in the anti-inflammatory potential of the vagus nerve (Huston et al., 2006), future studies are needed to determine whether the inhibition of the leukocyte migration in the carrageenan air pouch mode is due to the effect of vagus nerve on the foot or leukocyte differen…”
BackgroundInfluentialSelf-citationDevelopment of anti-TNF therapy for rheumatoid arthritis
Feldmann, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri802 · Cited by 673
Abraham, E. (1998) · The Lancet · doi:10.1016/s0140-6736(00)80009-4 · Cited by 624
Abraham, E. H., Anzueto, A., Gutiérrez, G., Tessler, S., Pedro, G. S. S., Wunderink, R. G., Nogare, A. R. D., Nasraway, S. A., Berman, S., Cooney, R. N., et al. (1998) · PubMed · Cited by 622
Lukas, R. J., Changeux, J.-P., le Novère, N., Albuquerque, E. X., Balfour, D. J. K., Berg, D. K., Bertrand, D., Chiappinelli, V. A., Clarke, P. B. S., Collins, A. C., et al. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01406-6 · Cited by 537
Cholinergic modulation of microglial activation by α7 nicotinic receptors
Shytle, R. D., Mori, T., Townsend, K., Vendrame, M., Sun, N., Zeng, J., Ehrhart, J., Silver, A. A., Sanberg, P. R., & Tan, J. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2004.02347.x · Cited by 534
Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding
Schottelius, A. J. G., Mayo, M. W., Sartor, R. B., & Baldwin, A. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31868 · Cited by 532
Pharmacological stimulation of the cholinergic antiinflammatory pathway
Bernik, T. R., Friedman, S. G., Ochani, M., DiRaimo, R., Ulloa, L., Yang, H., Sudan, S., Czura, C. J., Ivanova, S. M., & Tracey, K. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011714 · Cited by 529
Self-citationProof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia
Olincy, A., Harris, J. G., Johnson, L. L., Pender, V., Kongs, S., Allensworth, D., Ellis, J., Zerbe, G. O., Leonard, S., Stevens, K. E., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.630 · Cited by 527
Transdermal Nicotine for Active Ulcerative Colitis
Pullan, R. D., Rhodes, J., Ganesh, S., Mani, V., Morris, J. S., Williams, G. T., Newcombe, R. G., Russell, M., Feyerabend, C., Thomas, G., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403243301202 · Cited by 505 · cited 4×
“Seventy-seven patients diagnosed with active ulcerative colitis were treated with either transdermal nicotine or placebo patches for 6 weeks in a randomized, double-blind study (Pullan et al., 1994; Van Assche et al., 2005).”
BackgroundMethodInfluentialSaeed, R. W., Varma, S., Peng-Nemeroff, T., Sherry, B., Balakhaneh, D., Huston, J., Tracey, K. J., Al-Abed, Y., & Metz, C. N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040463 · Cited by 489
Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine1
WANG, R., YAN, H., & TANG, X.-C. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00255.x · Cited by 470
The vagus nerve and the nicotinic anti-inflammatory pathway
Ulloa, L. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1797 · Cited by 468
Self-citationThe ‘cytokine profile’: a code for sepsis
Ulloa, L., & Tracey, K. J. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.007 · Cited by 440
Self-citationWang, H., Lee, D. H. S., Davis, C. B., & Shank, R. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751155.x · Cited by 435
Ghia, J. E., Blennerhassett, P., Kumar–Ondiveeran, H., Verdu, E. F., & Collins, S. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.016 · Cited by 401
Murray, P. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500419102 · Cited by 394
Bertrand, D., Galzi, J. L., Devillers-Thiéry, A., Bertrand, S., & Changeux, J. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.6971 · Cited by 391
The Vagus Nerve and Nicotinic Receptors Modulate Experimental Pancreatitis Severity in Mice
van Westerloo, D. J., Giebelen, I. A., Florquin, S., Bruno, M. J., LaRosa, G. J., Ulloa, L., Tracey, K. J., & van der Poll, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.022 · Cited by 377
Self-citationAlpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia
Martin, L., Kem, W., & Freedman, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1750-1 · Cited by 342
High-mobility group box 1 (HMGB1) protein: Friend and foe
ULLOA, L., & MESSMER, D. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.01.003 · Cited by 341
Self-citationThe lymphocytic cholinergic system and its contribution to the regulation of immune activity
Kawashima, K., & Fujii, T. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.09.037 · Cited by 326
Neuronal Nicotinic Acetylcholine Receptors as Novel Drug Targets
Lloyd, G. K., & Williams, M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35314-5 · Cited by 313
Jenkins, B. J., Grail, D., Nheu, T., Najdovska, M., Wang, B., Waring, P., Inglese, M., McLoughlin, R. M., Jones, S. A., Topley, N., et al. (2005) · Nature Medicine · doi:10.1038/nm1282 · Cited by 308
Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve
Luyer, M. D., Greve, J. W. M., Hadfoune, M., Jacobs, J. A., Dejong, C. H., & Buurman, W. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042397 · Cited by 295
New Concepts in Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152209 · Cited by 290
Simone, R. D., Ajmone‐Cat, M. A., Carnevale, D., & Minghetti, L. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-4 · Cited by 275
Molecular mechanisms of interleukin-10-mediated inhibition of NF-κ B activity: a role for p50
DRIESSLER, F., VENSTROM, K., SABAT, R., ASADULLAH, K., & SCHOTTELIUS, A. J. (2003) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02342.x · Cited by 269
Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel
Bouzat, C., Gumilar, F., Spitzmaul, G., Wang, H.-L., Rayes, D., Hansen, S. B., Taylor, P., & Sine, S. M. (2004) · Nature · doi:10.1038/nature02753 · Cited by 267
Kawashima, K. (2004) · Frontiers in Bioscience · doi:10.2741/1390 · Cited by 259
YU, Z., ZHANG, W., & KONE, B. C. (2002) · Biochemical Journal · doi:10.1042/bj20020588 · Cited by 255 · cited 1×
“It should be mentioned that the NF-kB and the STAT3 pathway may converge and cooperate to relay inflammatory signaling, as the NF-kB p65 homodimer recruits and associates with STAT3 upon activation (Yu et al., 2002; Yoshida et al., 2004; Hoentjen et al., 2005).”
BackgroundGault, J., Robinson, M., Berger, R., Drebing, C., Logel, J., Hopkins, J., Moore, T., Jacobs, S., Meriwether, J., Choi, M. J., et al. (1998) · Genomics · doi:10.1006/geno.1998.5363 · Cited by 245
Suzuki, T., Hide, I., Matsubara, A., Hama, C., Harada, K., Miyano, K., Andrä, M., Matsubayashi, H., Sakai, N., Kohsaka, S., et al. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20850 · Cited by 241
Sato, K. Z., Fujii, T., Watanabe, Y., Yamada, S., Ando, T., Kazuko, F., & Kawashima, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00259-1 · Cited by 238
Kitagawa, H., Takenouchi, T., Azuma, R., Wesnes, K. A., Kramer, W. G., Clody, D. E., & Burnett, A. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300028 · Cited by 238
Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease
Downing, J. E. G., & Miyan, J. A. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01635-2 · Cited by 235
Interleukin‐10 suppression of myeloid cell activation — a continuing puzzle
Williams, L. M., Ricchetti, G., Sarma, U., Smallie, T., & Foxwell, B. M. J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01988.x · Cited by 234
van der Poll, T., & Lowry, S. F. (1995) · Shock · doi:10.1097/00024382-199501000-00001 · Cited by 230
Review article: infliximab therapy for inflammatory bowel disease – seven years on
RUTGEERTS, P., VAN ASSCHE, G., & VERMEIRE, S. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02786.x · Cited by 227
Matsunaga, K., Klein, T. W., Friedman, H., & Yamamoto, Y. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6518 · Cited by 225
Khiroug, S. S., Harkness, P. C., Lamb, P. W., Sudweeks, S. N., Khiroug, L., Millar, N. S., & Yakel, J. L. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013847 · Cited by 216
Neuronal α-Bungarotoxin Receptors Are α7 Subunit Homomers
Drisdel, R. C., & Green, W. N. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00133.2000 · Cited by 215
Aicher, A., Heeschen, C., Mohaupt, M., Cooke, J. P., Zeiher, A. M., & Dimmeler, S. (2003) · Circulation · doi:10.1161/01.cir.0000047279.42427.6d · Cited by 213
Nizri, E., Hamra-Amitay, Y., Sicsic, C., Lavon, I., & Brenner, T. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.10.013 · Cited by 205
Nicotinic α7 receptors: Synaptic options and downstream signaling in neurons
Berg, D. K., & Conroy, W. G. (2002) · Journal of Neurobiology · doi:10.1002/neu.10116 · Cited by 197
Green, G. M., & Carolin, D. (1967) · New England Journal of Medicine · doi:10.1056/nejm196702232760801 · Cited by 187
Arredondo, J., Chernyavsky, A. I., Jolkovsky, D. L., Pinkerton, K. E., & Grando, S. A. (2006) · The FASEB Journal · doi:10.1096/fj.06-6191com · Cited by 182
The innate signaling of dangers and the dangers of innate signaling
Sansonetti, P. J. (2006) · Nature Immunology · doi:10.1038/ni1420 · Cited by 181
Pharmacology of Neuronal Nicotinic Acetylcholine Receptor Subtypes
Colquhoun, L. M., & Patrick, J. W. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60072-1 · Cited by 180
Shaw, S., Bencherif, M., & Marrero, M. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204610200 · Cited by 172
Galzi, J.-L., Bertrand, D., Devillers-Thiéry, A., Revah, F., Bertrand, S., & Changeux, J.-P. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80668-s · Cited by 172
Smoking and inflammatory bowel disease
Rubin, D. T., & Hanauer, S. B. (2000) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200012080-00004 · Cited by 171
Charpantier, E., Wiesner, A., Huh, K.-H., Ogier, R., Hoda, J., Allaman, G., Raggenbass, M., Feuerbach, D., Bertrand, D., & Fuhrer, C. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3497-05.2005 · Cited by 169
Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells
Gahring, L. C., & Rogers, S. W. (2005) · The AAPS Journal · doi:10.1208/aapsj070486 · Cited by 168
Totti, N., McCusker, K. T., Campbell, E. J., Griffin, G. L., & Senior, R. M. (1984) · Science · doi:10.1126/science.6318317 · Cited by 159
Therapeutic Intervention and Targets for Sepsis
Rice, T. W., & Bernard, G. R. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104356 · Cited by 158
Williams, M. E., Burton, B., Urrutia, A., Shcherbatko, A., Chavez-Noriega, L. E., Cohen, C. J., & Aiyar, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410039200 · Cited by 152
Yoshida, Y., Kumar, A., Koyama, Y., Peng, H., Arman, A., Boch, J. A., & Auron, P. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311498200 · Cited by 150
Effect of smoking and abstention on oxidative burst and reactivity of neutrophils and monocytes
Sørensen, L. T., Nielsen, H. B., Kharazmi, A., & Gottrup, F. (2004) · Surgery · doi:10.1016/j.surg.2004.04.001 · Cited by 145
STAT3 regulates NF-κB recruitment to the IL-12p40 promoter in dendritic cells
Hoentjen, F., Sartor, R. B., Ozaki, M., & Jobin, C. (2004) · Blood · doi:10.1182/blood-2004-04-1309 · Cited by 142
Iho, S., Tanaka, Y., Takauji, R., Kobayashi, C., Muramatsu, I., Iwasaki, H., Nakamura, K., Sasaki, Y., Nakao, K., & Takahashi, T. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1202626 · Cited by 139
Papadopoulos, N. G., Alamanos, Y., Voulgari, P. V., et al. (2006) · PubMed · Cited by 132
Meyer, E. M., Kuryatov, A., Gerzanich, V., Lindstrom, J. M., & Papke, R. L. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37881-4 · Cited by 131
Sopori, M. L., Kozak, W., Savage, S. M., Geng, Y., Soszyński, D., Kluger, M. J., Perryman, E. K., & Snow, G. E. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00076-0 · Cited by 126
Mechanisms of Disease: nicotine—a review of its actions in the context of gastrointestinal disease
Thomas, G. A. O., Rhodes, J., & Ingram, J. R. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0316 · Cited by 124
Hamano, R., Takahashi, H. K., Iwagaki, H., Yoshino, T., Nishibori, M., & Tanaka, N. (2006) · Shock · doi:10.1097/01.shk.0000228168.86845.60 · Cited by 122
Sugano, N., Shimada, K., Ito, K., & Murai, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9599 · Cited by 115
Rat lymphocytes produce and secrete acetylcholine in dependence of differentiation and activation
Rinner, I., Kawashima, K., & Schauenstein, K. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00155-0 · Cited by 111
Expression of an α7 duplicate nicotinic acetylcholine receptor-related protein in human leukocytes
Villiger, Y., Szántó, I., Jaconi, S., Blanchet, C., Buisson, B., Krause, K.-H., Bertrand, D., & Romand, J.-A. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00057-7 · Cited by 103
Zhang, J., & Rivest, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00080.x · Cited by 98
The Molecular Biology of Neuronal Nicotinic Acetylcholine Receptors
Boyd, R. T. (1997) · Critical Reviews in Toxicology · doi:10.3109/10408449709089897 · Cited by 93
Reduced levels of Aβ 40 and Aβ 42 in brains of smoking controls and Alzheimer's patients
Hellström‐Lindahl, E., Mousavi, M. T., Ravid, R., & Nordberg, A. K. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.11.024 · Cited by 93
Neuronal α-Bungarotoxin Receptors Differ Structurally from Other Nicotinic Acetylcholine Receptors
Rangwala, F. A., Drisdel, R. C., Rakhilin, S., Ko, E., Atluri, P., Harkins, A. B., Fox, A. P., & Salman, A. W. N. G. S. B. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08201.1997 · Cited by 91
Nicotinic receptors regulate B lymphocyte activation and immune response
Skok, M., Grailhe, R., & Changeux, J.-P. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.05.011 · Cited by 88
The role of nicotinic acetylcholine receptors in lymphocyte development
Skok, M., Grailhe, R., Agenès, F., & Changeux, J. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.09.011 · Cited by 84
Hellström‐Lindahl, E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00028-5 · Cited by 83
A Randomized Trial of Nicotine Enemas for Active Ulcerative Colitis
Ingram, J. R., Thomas, G. A. O., Rhodes, J., Green, J. T., Hawkes, N., Swift, J., Srivastava, E. D., Evans, B. K., Williams, G. T., Newcombe, R. G., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00849-9 · Cited by 83
Gault, J., Hopkins, J. A., Berger, R., Drebing, C. J., Logel, J., Walton, C., Short, M., Vianzon, R., D, A. O. M., Ross, R. G., et al. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20061 · Cited by 83
Effect of nicotine on rectal mucus and mucosal eicosanoids.
Zijlstra, F. J., Srivastava, E. D., Rhodes, M. A., van Dijk, A. P. J., Fogg, F. J. J., Samson, H., Copeman, M., Russell, M. A., Feyerabend, C., & Williams, G. T. (1994) · Gut · doi:10.1136/gut.35.2.247 · Cited by 81
Relationship between α7 nAChR and apoptosis in human lymphocytes
Rosa, M. J. D., Esandi, M. D. C., Garelli, A., Rayes, D., & Bouzat, C. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.11.010 · Cited by 81
Nicotine prolongs neutrophil survival by suppressing apoptosis
Aoshiba, K., Nagai, A., Yasui, S., & Konno, K. (1996) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(96)90077-3 · Cited by 77
Yu, Z., & Kone, B. C. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000114556.19556.f9 · Cited by 70
Guinet, E., Yoshida, K., & Nouri-Shirazi, M. A. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.06.003 · Cited by 66
Marrero, M. B., Papke, R. L., Bhatti, B. S., Shaw, S., & Bencherif, M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061655 · Cited by 59
Vagal influences over mast cells
Stead, R. H., Colley, E. C., Wang, B., Partosoedarso, E. R., Lin, J., STANISZ, A. M., & Hillsley, K. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.01.002 · Cited by 54
Evidence for a noncholinergic nicotine receptor on human phagocytic leukocytes
Davies, B. D., Hoss, W. P., Lin, J.-P., & Lionetti, F. J. (1982) · Molecular and Cellular Biochemistry · doi:10.1007/bf00573842 · Cited by 53
α-Bungarotoxin Receptors Contain α7 Subunits in Two Different Disulfide-Bonded Conformations
Rakhilin, S., Drisdel, R. C., Sagher, D., McGehee, D. S., Vallejo, Y. F., & Green, W. N. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.1.203 · Cited by 53
Akk, G., & Steinbach, J. H. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4985-04.2005 · Cited by 47
Severance, E. G., Zhang, H., Cruz, Y., Pakhlevaniants, S., Hadley, S. H., Αmin, J., Wecker, L., Reed, C., & Cuevas, J. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000059 · Cited by 42
Blanchet, M., Israël-Assayag, É., Daleau, P., Beaulieu, M., & Cormier, Y. F. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00409.2005 · Cited by 35
Shaw, S., Bencherif, M., & Marrero, M. B. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11224.2003 · Cited by 32
Integrative neuroimmunology of the digestive tract.
Theodorou, Fioramonti, J., & Bueno, L. P. (1996) · PubMed · Cited by 31
Speer, P. D., Zhang, Y., Gu, Y., Lucas, M. J., & Wang, Y. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.121106 · Cited by 30
Medical treatment of inflammatory bowel diseases
Assche, G. V., Vermeire, S., & Rutgeerts, P. J. (2005) · Current Opinion in Internal Medicine · doi:10.1097/01.mog.0000166752.94169.ca · Cited by 28
Mandavilli, A. (2004) · Nature Medicine · doi:10.1038/nm0704-660 · Cited by 8
Cited by
Acetylcholine beyond neurons: the non‐neuronal cholinergic system in humans
Wessler, I., & Kirkpatrick, C. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.185 · Cited by 855
The pathogenesis of rheumatoid arthritis
Alivernini, S., Firestein, G. S., & McInnes, I. B. (2022) · Immunity · doi:10.1016/j.immuni.2022.11.009 · Cited by 702
Cholinergic control of inflammation
Rosas‐Ballina, M., & Tracey, K. J. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02098.x · Cited by 576
Olshansky, B., Sabbah, H. N., Hauptman, P. J., & Colucci, W. S. (2008) · Circulation · doi:10.1161/circulationaha.107.760405 · Cited by 456
Expression and Function of the Cholinergic System in Immune Cells
Fujii, T., Mashimo, M., Moriwaki, Y., Misawa, H., Ono, S., Horiguchi, K., & Kawashima, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01085 · Cited by 374
Metadata
- Authors
- de Jonge, W. J., & Ulloa, L.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-08
- Volume
- 151
- Issue
- 7
- Pages
- 915-929
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2161605623
- Cited by
- 629
- References
- 117
- FWCI
- 17.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.